Gene · 406934
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways. | Front Immunol | 2023 | 38193090 | PubTator, text mining | PubMed |
| Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas. | World J Gastroenterol | 2023 | 38186866 | PubTator, text mining | PubMed |
| Expression of E-cadherin and N-cadherin in Epithelial-to-Mesenchymal Transition of Osteosarcoma: A Systematic Review. | Cureus | 2023 | 38156135 | PubTator, text mining | PubMed |
| Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. | Front Immunol | 2023 | 38152407 | PubTator, text mining | PubMed |
| Mapping of the gene network that regulates glycan clock of ageing. | Aging (Albany NY) | 2023 | 38149987 | PubTator, text mining | PubMed |
| COVID-19 Vaccination in Pregnancy: Pilot Study for Maternal and Neonatal MicroRNA Profiles. | Vaccines (Basel) | 2023 | 38140218 | PubTator, text mining | PubMed |
| Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. | Int J Mol Sci | 2023 | 38139352 | PubTator, text mining | PubMed |
| A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples. | Biomolecules | 2023 | 38136554 | PubTator, text mining | PubMed |
| WWP1 E3 ligase at the crossroads of health and disease. | Cell Death Dis | 2023 | 38129384 | PubTator, text mining | PubMed |
| Association between erythrocyte membrane fatty acids and gut bacteria in obesity-related cognitive dysfunction. | AMB Express | 2023 | 38123761 | PubTator, text mining | PubMed |
| Targeting NAD+ metabolism: dual roles in cancer treatment. | Front Immunol | 2023 | 38116009 | PubTator, text mining | PubMed |
| Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications. | Cell Commun Signal | 2023 | 38111040 | PubTator, text mining | PubMed |
| Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors. | Front Immunol | 2023 | 38077327 | PubTator, text mining | PubMed |
| miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD. | Open Med (Wars) | 2023 | 38075030 | PubTator, text mining | PubMed |
| Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications. | Front Physiol | 2023 | 38074330 | PubTator, text mining | PubMed |
| Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. | Nat Genet | 2023 | 38049665 | PubTator, text mining | PubMed |
| lncRNA TPRG1-AS1 Screened the Onset of Acute Coronary Syndromes and Predicted Severity and the Occurrence of MACE During Patients' Hospitalization. | J Inflamm Res | 2023 | 38026258 | PubTator, text mining | PubMed |
| Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis. | J Bone Oncol | 2023 | 38021072 | PubTator, text mining | PubMed |
| circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. | Aging (Albany NY) | 2023 | 38015711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406934/papers?page=6